文献速递腹部技术与安全CT

结直肠癌筛查中的CT结肠成像:流程、成本效益、效率与进展

Colon cancer screening with CT colonography: logistics, cost-effectiveness, efficiency and progress.
PubMed 文献 · Br J Radiol · 2018-07-05

本文综述了CT结肠成像(CTC)用于人群结直肠癌筛查的流程挑战、准确性、摄取率、质量保证与成本效益。CTC对进展期腺瘤的检出率与结肠镜相当,侵入性更小、所需泻药更少,并可评估结肠外结构。三项欧洲大型试验支持CTC用于人群筛查,未来研究可能聚焦放射科医师培训与质量保证的关键绩效指标。

要点

  • CTC对进展期腺瘤的检出率与结肠镜相当,且侵入性更小、所需泻药更少。
  • 三项欧洲大型试验提供了支持CTC用于人群筛查的证据,并强调应根据初始CTC结果选择临床管理路径。
  • 与其他筛查技术相比,CTC安全准确,在结肠镜禁忌时尤为有用。

核心结论

  • CTC对进展期腺瘤的检出率与结肠镜相当,是侵入性更小、所需泻药更少的替代方法,并可评估结肠外结构。
  • 三项欧洲大型试验支持CTC用于人群筛查,并强调根据初始CTC结果选择适当临床管理路径的重要性。
  • 与其他结直肠癌筛查技术相比,CTC提供安全准确的选项,在结肠镜禁忌时尤为有用。

研究设计与样本

  • 综述,聚焦CT结肠成像(CTC)用于人群结直肠癌筛查的流程、成本效益、效率与进展。
  • 文中引用三项欧洲大型试验作为支持CTC用于人群筛查的证据。

诊断标准与关键数值

  • CTC对进展期腺瘤的检出率与结肠镜相当。

临床应用与阅片要点

  • 应根据初始CTC发现选择适当的临床管理路径。
  • 未来CTC筛查研究可能聚焦放射科医师培训与CTC质量保证,并识别与临床相关结局(如检测后间隔期癌症,即 presumed negative CTC 后发生的结直肠癌)相关的循证关键绩效指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Colorectal cancer (CRC) incidence and mortality can be significantly reduced by population screening. Several different screening methods are currently in use, and this review focuses specifically on the imaging technique computed tomographic colonography (CTC). The challenges and logistics of CTC screening, as well as the importance of test accuracy, uptake, quality assurance and cost-effectiveness will be discussed. With comparable advanced adenoma detection rates to colonoscopy (the most commonly used whole-colon investigation), CTC is a less-invasive alternative, requiring less laxative, and with the potential benefit that it permits assessment of extra colonic structures. Three large-scale European trials have contributed valuable evidence supporting the use of CTC in population screening, and highlight the importance of selecting appropriate clinical management pathways based on initial CTC findings. Future research into CTC-screening will likely focus on radiologist training and CTC quality assurance, with identification of evidence-based key performance indicators that are associated with clinically-relevant outcomes such as the incidence of post-test interval cancers (CRC occurring after a presumed negative CTC). In comparison to other CRC screening techniques, CTC offers a safe and accurate option that is particularly useful when colonoscopy is contraindicated. Forthcoming cost-effectiveness analyses which evaluate referral thresholds, the impact of extra-colonic findings and real-world uptake will provide useful information regarding the feasibility of future CTC population screening.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Obaro AE, Burling DN, Plumb AA, et al. Colon cancer screening with CT colonography: logistics, cost-effectiveness, efficiency and progress. Br J Radiol. 2018. PMID: 29927637. doi:10.1259/bjr.20180307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。